Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Urological Agent"'
Publikováno v:
International Journal of Clinical Practice. 67:544-551
Summary Background As the clinical effects of the available α1-adrenoceptors (ARs) blockers are usually considered comparable for treatment in patients suffering from lower urinary tract symptoms (LUTS) secondary to prostatic enlargement, officially
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8befb94172f8a096f44681535a68eba3
https://doi.org/10.1111/ijcp.12135
https://doi.org/10.1111/ijcp.12135
Autor:
Giorgio Franco, Benedetto Torrisi, Sebastiano Cimino, T. Tony Cai, Mauro Silvani, Giovanna Russo, Maurizio Madonia, Paolo Verze, Giuseppe D'Achille, Giovanni Liguori, Salvatore Privitera, Alessandro Palmieri, Vincenzo Favilla, G. Siracusa, Giuseppe Morgia, Giorgio Cavallini, Alessandro Zucchi, Vincenzo Mirone
Publikováno v:
Andrology. 5(4)
Several intralesional therapeutic protocols have been proposed for the treatment of Peyronie's disease. Among all, hyaluronic acid (HA) and verapamil have been differently tested. We aimed to evaluate the efficacy of intralesional verapamil (ILVI) co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::897b5bd27366aec55d119349ccb18d0b
https://pubmed.ncbi.nlm.nih.gov/28718527
https://pubmed.ncbi.nlm.nih.gov/28718527
Autor:
Alessandro Serino, Paolo Capogrosso, Eugenio Ventimiglia, Luca Boeri, Alberto Briganti, Rocco Damiano, Andrea Salonia, Federico Dehò, F. Montorsi
The treatment with α1-blockers in patients complaining of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) is associated with potential adverse events (AEs), thus including ejaculatory dysfunction (EjD). We sought t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::132e08e0f3fc0aef0c4a113220d6b818
http://hdl.handle.net/11383/2118543
http://hdl.handle.net/11383/2118543
